SE435382B - Forfarande for framstellning av 1-(((5-(substituerad fenyl-2-oxazolyl) metylen)amino)-2,4-imidazolidindioner - Google Patents

Forfarande for framstellning av 1-(((5-(substituerad fenyl-2-oxazolyl) metylen)amino)-2,4-imidazolidindioner

Info

Publication number
SE435382B
SE435382B SE7710086A SE7710086A SE435382B SE 435382 B SE435382 B SE 435382B SE 7710086 A SE7710086 A SE 7710086A SE 7710086 A SE7710086 A SE 7710086A SE 435382 B SE435382 B SE 435382B
Authority
SE
Sweden
Prior art keywords
imidazolide
india
oxazolyl
amino
methyl
Prior art date
Application number
SE7710086A
Other languages
English (en)
Swedish (sv)
Other versions
SE7710086L (sv
Inventor
Jr R L White
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of SE7710086L publication Critical patent/SE7710086L/xx
Publication of SE435382B publication Critical patent/SE435382B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7710086A 1976-10-18 1977-09-08 Forfarande for framstellning av 1-(((5-(substituerad fenyl-2-oxazolyl) metylen)amino)-2,4-imidazolidindioner SE435382B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/733,296 US4049650A (en) 1976-10-18 1976-10-18 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones

Publications (2)

Publication Number Publication Date
SE7710086L SE7710086L (sv) 1978-04-19
SE435382B true SE435382B (sv) 1984-09-24

Family

ID=24947035

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7710086A SE435382B (sv) 1976-10-18 1977-09-08 Forfarande for framstellning av 1-(((5-(substituerad fenyl-2-oxazolyl) metylen)amino)-2,4-imidazolidindioner

Country Status (14)

Country Link
US (1) US4049650A (fr)
JP (1) JPS5350167A (fr)
AU (1) AU505351B2 (fr)
BE (1) BE859819A (fr)
CA (1) CA1084510A (fr)
CH (1) CH629800A5 (fr)
DE (1) DE2746550A1 (fr)
ES (1) ES463297A1 (fr)
FR (1) FR2367763A1 (fr)
GB (1) GB1530770A (fr)
MX (1) MX5011E (fr)
NL (1) NL7711416A (fr)
SE (1) SE435382B (fr)
ZA (1) ZA775228B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657559A1 (de) * 1976-12-18 1978-06-22 Bayer Ag Dioxopiperazinderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und als zwischenprodukte fuer beta-lactamantibiotika
US4128711A (en) * 1977-10-06 1978-12-05 Morton-Norwich Products, Inc. 1-[[1H-Pyrrol-2-ylmethylene]amino]-2,4-imidazolidinedione
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4861790A (en) * 1987-10-28 1989-08-29 Norwich Eaton Pharmaceuticals, Inc. Use of azumolene for the treatment of malignant hyperthermia
WO2007145203A1 (fr) * 2006-06-13 2007-12-21 Daiichi Fine Chemical Co., Ltd. 2-amino-1-(4-fluorophenyl) éthanol optiquement actif
ES2687780T3 (es) 2009-09-30 2018-10-29 Shiseido Company, Ltd. Inhibidor de la actividad heparanasa
HUP1300720A2 (hu) * 2013-12-12 2015-06-29 Univ Szegedi Gyógyászati készítmények sebgyógyulás elõsegítésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415821A (en) * 1965-09-07 1968-12-10 Norwich Pharma Co 1-(5-substituted)furfurylideneamino hydantoins and imidazolidinones
DE2106298A1 (fr) * 1971-02-10 1972-10-12
US3803136A (en) * 1972-08-23 1974-04-09 Morton Norwich Products Inc 5-hydroxy-1-((5-(substituted phenyl)furfurylidene)amino)hydrantoins
US3843636A (en) * 1974-01-25 1974-10-22 Morton Norwich Products Inc 1-(5-(p-methoxyphenyl)furfurylidene)amino)hydantoin
US4001222A (en) * 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof

Also Published As

Publication number Publication date
JPS6225148B2 (fr) 1987-06-01
CA1084510A (fr) 1980-08-26
CH629800A5 (de) 1982-05-14
GB1530770A (en) 1978-11-01
ZA775228B (en) 1979-04-25
ES463297A1 (es) 1978-11-16
MX5011E (es) 1983-02-16
NL7711416A (nl) 1978-04-20
DE2746550A1 (de) 1978-04-20
JPS5350167A (en) 1978-05-08
FR2367763A1 (fr) 1978-05-12
AU2803677A (en) 1979-02-22
BE859819A (fr) 1978-04-17
DE2746550C2 (fr) 1987-10-15
US4049650A (en) 1977-09-20
AU505351B2 (en) 1979-11-15
SE7710086L (sv) 1978-04-19
FR2367763B1 (fr) 1980-06-27

Similar Documents

Publication Publication Date Title
DK157487C (da) Analogifremgangsmaade til fremstilling af prolinderivater.
SE431753B (sv) Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner
DK151260C (da) Analogifremgangsmaade til fremstilling af spiro-thienohydantoinderivater.
DK520077A (da) Fremgangsmaade til fremstilling af 5-(hydroxysubstitueret-methhyl)-2,3-dihydrobenzofuran-2-carboxylsyrer eller salte estere eller amider deraf
DK118277A (da) Fremgangsmade til fremstilling af n-5-tetrazololyl)-4-oxo-4h-pyrimido (2,1-b)benzothiazol-3-carboxamider
DK387177A (da) Fremgangsmaade til fremstilling af derivater af perhydro-aza-heterocycler
DK55677A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO156086C (no) Analogifremgangsmaate for fremstilling av substituerte heterocykliske fenoksyaminer.
DK243477A (da) Fremgangsmade til fremstilling af 10,19-dihydrovitamin d forbindelser
DK148538C (da) Analogifremgangsmaade til fremstilling af 2,3-substituerede 4-pyroner
DK185577A (da) Fremgangsmade til fremstilling af heterocycliske forbindelser
SE435382B (sv) Forfarande for framstellning av 1-(((5-(substituerad fenyl-2-oxazolyl) metylen)amino)-2,4-imidazolidindioner
DK80777A (da) Fremgangsmade til fremstilling af 2,3-substituerede, 5,6-kondenserede 4(2h)-aminoalkoxypyranoner
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK227277A (da) Fremgangsmade til fremstilling af 1,3-disubstituerede nitrosourinstoffer
DK233377A (da) Fremgangsmade til fremstilling af omega-noraromatiske-13,14-dehydro-prostaglandiner
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK326377A (da) Fremgangsmade til fremstilling af n-(1i-allyl-2i-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
DK528777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
NO152971C (no) Analogifremgangsmaate for fremstilling av n-(1-metyl-2-pyrrolidinyl-metyl)-2,3-dimetoksy-5-metylsulfamoyl-benzamid og derivater derav.
SE421792B (sv) Forfarande for framstellning av n-(2-pyridyl)-4-hydroxi-2-metyl-2h-1,2-benso-tiazin-3-karboxamid-1,1-dioxid
DK566277A (da) Fremgangsmaade til fremstilling af 1-aminoalkyl3,4-diphenyl-1h-pyrazoler
DK301177A (da) Fremgangsmade til fremstilling af 6a,10a-cishexahydrodibenzopyranoner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7710086-5

Effective date: 19930406

Format of ref document f/p: F